Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis

V. Cecchin, M.E. Zannin, D. Ferrari, I. Pontikaki, E. Miserocchi, M.P. Paroli, C. Bracaglia, D.P. Marafon, S. Pastore, F. Parentin, G. Simonini, C. De Libero, F. Falcini, A. Petaccia, G. Filocamo, R. De Marco, F. La Torre, S. Guerriero, S. Martino, F. ComacchioV. Muratore, G. Martini, F. Vittadello, F. Zulian

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1167-1172
Number of pages6
JournalJournal of Rheumatology
Volume45
Issue number8
DOIs
Publication statusPublished - 2018

Cite this

Cecchin, V., Zannin, M. E., Ferrari, D., Pontikaki, I., Miserocchi, E., Paroli, M. P., Bracaglia, C., Marafon, D. P., Pastore, S., Parentin, F., Simonini, G., De Libero, C., Falcini, F., Petaccia, A., Filocamo, G., De Marco, R., La Torre, F., Guerriero, S., Martino, S., ... Zulian, F. (2018). Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis. Journal of Rheumatology, 45(8), 1167-1172. https://doi.org/10.3899/jrheum.171006